While the precise pathogenic mechanism of mAb-associated PML remains elusive, the involvement of CD4+- and CD8+-lymphopenia is postulated as a risk factor in at least some of these patients [5]. The gene discussed is CD8A; the disease is progressive multifocal leukoencephalopathy.